Henry Schein, Inc. (NASDAQ:HSIC) Receives $81.10 Consensus PT from Analysts

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eleven brokerages that are currently covering the firm, Marketbeat reports. Five analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $81.10.

Several brokerages have issued reports on HSIC. UBS Group lowered their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. StockNews.com lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Jefferies Financial Group upped their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and lifted their price target for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Finally, Wells Fargo & Company assumed coverage on Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price objective for the company.

Henry Schein Trading Down 1.5 %

Shares of HSIC stock traded down $0.98 during trading hours on Monday, reaching $65.25. The company had a trading volume of 157,714 shares, compared to its average volume of 1,613,477. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein has a 1-year low of $60.56 and a 1-year high of $82.49. The company has a 50 day moving average of $69.46 and a 200 day moving average of $71.81. The firm has a market cap of $7.99 billion, a price-to-earnings ratio of 26.84, a P/E/G ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm's revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.66 EPS. On average, equities research analysts anticipate that Henry Schein will post 4.74 EPS for the current year.

Insiders Place Their Bets

In related news, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Hedge Funds Weigh In On Henry Schein

Several institutional investors and hedge funds have recently modified their holdings of HSIC. Moran Wealth Management LLC acquired a new position in Henry Schein in the 1st quarter valued at about $3,977,000. Figure 8 Investment Strategies LLC boosted its holdings in shares of Henry Schein by 11.5% during the first quarter. Figure 8 Investment Strategies LLC now owns 8,667 shares of the company's stock worth $594,000 after acquiring an additional 895 shares during the period. Oppenheimer Asset Management Inc. grew its position in shares of Henry Schein by 5.2% in the first quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock valued at $941,000 after purchasing an additional 678 shares during the last quarter. State of Alaska Department of Revenue increased its stake in shares of Henry Schein by 2.8% during the first quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock worth $1,000,000 after purchasing an additional 395 shares during the period. Finally, Rakuten Securities Inc. acquired a new stake in Henry Schein during the 1st quarter worth approximately $34,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.